Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences

Rhea-AI Summary

Jazz Pharmaceuticals (Nasdaq: JAZZ) will participate in two key investor conferences in June 2024: the Jefferies Global Healthcare Conference on June 6 and the Goldman Sachs 45th Annual Global Healthcare Conference on June 12. The company will conduct fireside chats at both events, with audio webcasts available on their website. Jazz Pharmaceuticals focuses on developing medicines for serious diseases, including sleep disorders, epilepsy, and cancer. With headquarters in Dublin, Ireland, Jazz operates globally, driven by a patient-focused and science-driven approach.

Positive

• Participation in major investor conferences can increase investor interest and visibility.
• Jazz Pharmaceuticals has a diverse portfolio, including leading therapies for sleep disorders and epilepsy, and an expanding cancer treatment range.
• Global presence with research and development facilities in multiple countries.

Negative

• No new financial or clinical updates were provided in the press release.
• The stock might experience volatility around these conferences based on discussions and analyst perceptions.

DUBLIN, May 29, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences:

Jefferies Global Healthcare Conference on Thursday, June 6, 2024

• Fireside chat at 11:00 a.m. PT / 2:00 p.m. ET / 7:00 p.m. IST

Goldman Sachs 45^th Annual Global Healthcare Conference on Wednesday, June 12, 2024

• Fireside chat at 7:40 a.m. PT / 10:40 a.m. ET / 3:40 p.m. IST

Audio webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.

Contacts:

Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-june-investor-conferences-302158364.html

SOURCE Jazz Pharmaceuticals plc

FAQ

When will Jazz Pharmaceuticals participate in the Jefferies Global Healthcare Conference?

Jazz Pharmaceuticals will participate in the Jefferies Global Healthcare Conference on June 6, 2024.

What is the date of the Goldman Sachs 45th Annual Global Healthcare Conference?

The Goldman Sachs 45th Annual Global Healthcare Conference will take place on June 12, 2024.

Will the Jazz Pharmaceuticals' presentations at the conferences be available online?

Yes, audio webcasts of Jazz Pharmaceuticals' presentations will be available on their website, with replays archived for 30 days.

What is the stock symbol for Jazz Pharmaceuticals?

The stock symbol for Jazz Pharmaceuticals is JAZZ.